Your browser doesn't support javascript.
loading
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
McComish, Jeremy S; Slade, Charlotte A; Buizen, Luke; Paul, Sanjoy K; Chatelier, Josh W; Unglik, Gary; Nicholls, Katherine A; Spriggs, Kymble; Chan, Samantha S; Godsell, Jack; Auyeung, Priscilla; Tan, Zi Hao; DeLuca, Joseph; Patel, Mittal; Kuek, Lin Eon; Tran, Yang; Kern, Johannes S; Scardamaglia, Laura; Varigos, George A; Juneja, Surender; Grabek, Julian A; Christie, Michael; Mackay, Graham A; Douglass, Jo A.
Affiliation
  • McComish JS; Royal Melbourne Hospital, Parkville, Victoria, Australia. Electronic address: reception@victorianimmunology.com.au.
  • Slade CA; Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
  • Buizen L; Royal Melbourne Hospital, Parkville, Victoria, Australia; Melbourne EpiCentre, University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
  • Paul SK; Royal Melbourne Hospital, Parkville, Victoria, Australia; Melbourne EpiCentre, University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
  • Chatelier JW; Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Unglik G; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Nicholls KA; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Spriggs K; Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Chan SS; Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Godsell J; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Auyeung P; Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
  • Tan ZH; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • DeLuca J; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Patel M; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Kuek LE; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia.
  • Tran Y; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Kern JS; Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • Scardamaglia L; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Varigos GA; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Juneja S; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Grabek JA; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Christie M; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Mackay GA; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia.
  • Douglass JA; Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; Melbourne EpiCentre, University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
J Allergy Clin Immunol Pract ; 11(7): 2248-2250.e3, 2023 07.
Article in En | MEDLINE | ID: mdl-37088371
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis / Anti-Allergic Agents / Mastocytosis, Cutaneous / Mastocytosis, Systemic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2023 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis / Anti-Allergic Agents / Mastocytosis, Cutaneous / Mastocytosis, Systemic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2023 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA